JAMES BAILEY: Open Payments
NPI 1194112375 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 23 payments from 7 companies in 2025. Trend: 2023 $449 · 2024 $659 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $144 |
| ACADIA Pharmaceuticals Inc | 1 | $40 |
| Amgen Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $4 |
Products named: UBRELVY, DAYBUE, VRAYLAR, EVENITY, GLASSIA, REXULTI, QULIPTA, VOQUEZNA.
Industry payments across ID — which companies pay providers there.
